Pathogenic expansion: fibroblast proliferation fuels fibrosis

Area of Science:

• Pulmonary medicine
• Cell biology
• Fibrosis research

Background:

• Pulmonary fibrosis is characterized by lung scarring, fibroblast expansion, and extracellular matrix deposition.
• The precise role of fibroblast proliferation in driving fibrotic disease progression remains incompletely understood.

Purpose of the Study:

• To investigate the mechanistic role of fibroblast proliferation as a critical driver of pulmonary fibrosis.
• To explore therapeutic strategies targeting fibroblast proliferation in preclinical models of lung fibrosis.

Main Methods:

• Utilized lineage tracing in preclinical fibrosis models to track fibroblast behavior.
• Employed genetic manipulation (Esco2 deletion for apoptosis induction, Ect2 deletion for proliferation inhibition) in fibroblasts.
• Analyzed explanted human lung tissue to assess translational relevance.

Main Results:

• Naive Scube2+ alveolar fibroblasts undergo a profibrotic phenotypic switch before proliferating in fibrotic areas.
• Induction of apoptosis or prevention of proliferation in these fibroblasts significantly attenuated lung fibrosis.
• Findings were corroborated by analyses of human fibrotic lung tissue.

Conclusions:

• Fibroblast proliferation is a critical and actionable driver of pulmonary fibrosis.
• Targeting fibroblast proliferation pathways presents a promising therapeutic strategy for treating fibrotic lung diseases.